Trial Profile
Telaprevir + ritonavir in fed male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Mar 2011
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Ritonavir
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors Janssen Infectious Diseases BVBA; Vertex Pharmaceuticals
- 16 Mar 2011 New trial record
- 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.